Insulet Corporation Revenue and Competitors
Estimated Revenue & Valuation
- Insulet Corporation's estimated annual revenue is currently $1B per year.
- Insulet Corporation received $340.2M in venture funding in November 2017.
- Insulet Corporation's estimated revenue per employee is $290,179
- Insulet Corporation's total funding is $129.5M.
- Insulet Corporation's current valuation is $16.7B. (January 2022)
Employee Data
- Insulet Corporation has 3584 Employees.
- Insulet Corporation grew their employee count by 6% last year.
Insulet Corporation's People
Name | Title | Email/Phone |
---|---|---|
1 | Product Owner | Reveal Email/Phone |
2 | Sr. VP, Regulatory, Quality Assurance and Compliance | Reveal Email/Phone |
3 | Global VP, Regulatory & Clinical Affairs & Quality Assurance | Reveal Email/Phone |
4 | Group VP - Chief Procurement Officer | Reveal Email/Phone |
5 | Group VP Global Operations | Reveal Email/Phone |
6 | VP, Chief Information Security Officer | Reveal Email/Phone |
7 | ceo | Reveal Email/Phone |
8 | Global Head & VP Talent, Culture & Diversity | Reveal Email/Phone |
9 | EVP, CFO and Treasurer | Reveal Email/Phone |
10 | Head Market Access, UK & Benelux | Reveal Email/Phone |
Insulet Corporation Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $9.8M | 39 | 3% | N/A | N/A |
#2 | $8.5M | 34 | 3% | N/A | N/A |
#3 | $3M | 12 | -29% | N/A | N/A |
#4 | $5630M | 7477 | -11% | $450M | N/A |
#5 | $4.5M | 18 | 6% | N/A | N/A |
#6 | $7.2M | 57 | 27% | $29.6M | N/A |
#7 | $14.3M | 57 | -12% | N/A | N/A |
#8 | $2.3M | 18 | 6% | $44M | N/A |
#9 | $40.7M | 162 | -1% | N/A | N/A |
#10 | $45.7M | 182 | -5% | N/A | N/A |
What Is Insulet Corporation?
About Insulet Corporation: Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnpod technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 100,000 users across the globe rely on Insulet's Omnipod Insulin Management System to bring simplicity and freedom to their lives. For more information, please visit: www.insulet.com, www.myomnipod.com and https://www.omnipodeurope.com.* *Starting July 1, 2018, Insulet will assume direct distribution of its Omnipod Insulin Management System in Europe, including sales, marketing, training and customer support activities. This will allow Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long term, as it already does in the United States and Canada.
keywords:Biotechnology,Healthcare,Medical Devices$129.5M
Total Funding
3584
Number of Employees
$1B
Revenue (est)
6%
Employee Growth %
$16.7B
Valuation
N/A
Accelerator
Insulet Corporation News
Analysts expect the company to announce earnings of $0.24 per share for the quarter. Insulet has set its Q1 2022 guidance at EPS and its FY...
BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its...
Several equities research analysts have weighed in on the company. UBS Group upgraded Insulet from a neutral rating to a buy rating and...
Shares of Insulet Corporation (PODD) (The Insulin Provider) for example have been on a relentless rally since they bottomed in 2009.
Insulet Corporation (PODD):. If you are considering getting into the day trading or penny stock market, it's a legitimate and profitable method for ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2360M | 4804 | 7% | $22.5M |
#2 | $865.2M | 5582 | 7% | N/A |
#3 | $2180M | 6149 | 3% | N/A |
Insulet Corporation Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2002-10-07 | $22.0M | Spending On: Undiscl | Article | |
2004-03-03 | $35.5M | Undisclosed | Alta Partners | Article |
2006-02-17 | $50.0M | Undisclosed | The Federated Kaufman Fund | Article |
2009-03-17 | $60.0M | Undisclosed | Deerfield Management Company | Article |
2016-09-07 | $250.0M | Undisclosed | Article | |
2017-11-09 | $340.2M | Undisclosed | Article |